Morgan Stanley Maintains Equal-Weight on Outset Medical, Lowers Price Target to $19
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Drew Ranieri has maintained an Equal-Weight rating on Outset Medical (NASDAQ:OM) and lowered the price target from $22 to $19.
August 24, 2023 | 1:41 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Outset Medical's price target has been lowered from $22 to $19 by Morgan Stanley, while maintaining an Equal-Weight rating.
The lowering of the price target by a major financial institution like Morgan Stanley could negatively impact investor sentiment towards Outset Medical, potentially leading to a short-term decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100